SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Provectus Biopharmaceuticals Inc. (PVCT)

PVCT RSS Feed
Add PVCT Price Alert      Hide Sticky   Hide Intro
Moderator: Mokyo Toe
Search This Board: 
Last Post: 11/17/2017 8:19:49 PM - Followers: 194 - Board type: Free - Posts Today: 0







Business Description

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer and liver cancer. Provectus investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for psoriasis. In addition, Provectus has begun a Phase 3 trial as a therapy for metastatic melanoma. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com.

The red synthetic dye Rose Bengal is shown in a bottle at Provectus Pharmaceuticals, Inc.


 


CURRENT PVCT PIPELINE (as of May 23, 2017)

--------------------------------------------------------------

Charts and Technical:

PVCT 6 months chart:
http://stockcharts.com/h-sc/ui?s=PVCT&p=D&yr=0&mn=6&dy=0&id=p03754661229

Technical analysis:
http://www.stockta.com/cgi-bin/analysis.pl?symb=PVCT&num1=7&cobrand=&mode=stock

PVCT News and Analysis:

PVCT News Blog with the latest news and analysis:

http://provectuspharmaceuticalsinc.blogspot.ca/p/news.html 

CONNECTING THE DOTS - CURRENT NEWS PAGE
http://provectuspharmaceuticalsinc.blogspot.ca/p/current-news_22.html

CONNECTING THE DOTS - BLOG PAGE

http://provectuspharmaceuticalsinc.blogspot.ca/


PVCT News at OTC 
http://www.otcmarkets.com/stock/PVCT/news

CLINICAL TRIALS Updates and Info:

FOR PV-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PV-10&Search=Search

FOR PH-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PH-10&Search=Search

PVCT insiders transactions:
http://www.secform4.com/insider/showhistory.php?symbol=pvct



For Clinical Trials and Compassionate Use Programs, Investor Information including SEC filing and Corporate Presentations, Press and Media Releases, and Contact information:
http://www.pvct.com/index.html

PVCT on YouTube...
http://www.youtube.com/watch?v=nuYpvcnAq4c

------------------------------------------------------------

Contact Info:

Telephone: (866) 594-5999
info@pvct.com
scott@pvct.com

Mailing Address:

Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Hwy
Knoxville, TN 37931 USA

--------------------------------------------------------------

PVCT Share Structure
Market Value:  $18,517,732 a/o May 04, 2017
Authorized Shares:  1,000,000,000  a/o Apr 30, 2017
Outstanding Shares:  370,354,643  a/o Apr 30, 2017
-Restricted:  N/A
-Unrestricted:  N/A
Held at DTC: N/A
Float:  75,807,312  a/o Jun 30, 2016
Par Value:  0.001
Transfer Agent  Broadridge Financial Solutions, Inc.
Shareholders of Record:  972 a/o Mar 31, 2017
Short Selling Data
Short Interest 167,323 (69.16%)
Apr 13, 2017
Significant Failures to Deliver No





Insider Shares:
http://www.nasdaq.com/symbol/pvct/insider-trades

Institutional Ownership:
http://www.nasdaq.com/symbol/pvct/institutional-holdings

--------------------------------------------------------------

10Q Filed May 10, 2017:


https://ih.advfn.com/p.php?pid=nmona&article=74554789

8K Filed June 1, 2017; Board elected, no share increase

http://ih.advfn.com/p.php?pid=nmona&article=74843932&symbol=PVCT

8K filed August 1, 2017; Provectus Biopharmaceuticals, Inc. is entitled to receive total damages of $6,027,652

http://ih.advfn.com/p.php?pid=nmona&article=75359078

8K filed October 18, 2917; Provectus announces results from the Company’s ongoing Phase 1b/2 study of IL PV-10 in combination with KEYTRUDA® (pembrolizumab)

https://www.sec.gov/Archives/edgar/data/315545/000149315217011744/ex99-1.htm
SureTrader
Interactive Brokers Advertisement
PVCT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#9247  Sticky Note NEWS -- PROVECTUS ANNOUNCES PRELIMINARY RESULTS FROM PHASE Paulness 10/18/17 11:29:03 AM
#9275   I'm not the patient one or the painter Work Harder 11/17/17 08:19:49 PM
#9274   Only that someone has $75k laying around that James Bond 007 11/15/17 05:36:56 PM
#9273   Our little daily paint jobber was absent today. Mokyo Toe 11/15/17 04:10:23 PM
#9272   Somebody is loading up big on the bid. bombaytonic 11/14/17 12:57:19 PM
#9271   Appreciate the update, jondoeuk. We have seen more Mokyo Toe 11/14/17 08:36:39 AM
#9270   Let's hope it doesn't take too long to jondoeuk 11/13/17 10:50:27 PM
#9269   The PhII PH-10 trial has just been completed https://clinicaltrials.gov/ct2/show jondoeuk 11/13/17 10:46:47 PM
#9268   10-Q is out Mokyo Toe 11/08/17 07:06:26 PM
#9267   PR out: PROVECTUS BIOPHARMACEUTICALS RECEIVES SECOND CANCER COMBINATION Mokyo Toe 11/07/17 05:49:17 PM
#9266   That "community sentiment" indicator iHub added (shrinking the Mokyo Toe 11/07/17 11:40:10 AM
#9265   PROVECTUS & PFIZER ASSIGNED PATENT NUMBER 9808524 Mokyo Toe 11/07/17 05:32:20 AM
#9264   Nice! Highest close since June 13th. Mokyo Toe 11/03/17 04:00:46 PM
#9263   hmmm...sumbuddy is buying down here freshy 11/02/17 11:42:53 AM
#9261   Making a move over .04; I think we Mokyo Toe 11/02/17 10:15:56 AM
#9260   Looks like PVCT is in right direction and shawnb 11/01/17 10:07:25 PM
#9259   Not sure what you posted, but it came Mokyo Toe 11/01/17 08:57:30 PM
#9258   shawnb 11/01/17 08:34:24 PM
#9257   Provectus to be granted a new patent... Mokyo Toe 11/01/17 04:48:17 PM
#9256   Got it Work Harder 10/23/17 07:20:18 PM
#9255   The whole board was replaced in May; we Mokyo Toe 10/23/17 07:18:13 PM
#9254   Thanks, for the recap Work Harder 10/23/17 07:09:32 PM
#9253   In last month's letter to shareholders, the first Mokyo Toe 10/23/17 07:05:54 PM
#9252   Still need to do what ya think Work Harder 10/23/17 06:53:49 PM
#9251   NEWS - PROVECTUS ANNOUNCES RESULTS FROM ELICITATION STUDY Mokyo Toe 10/23/17 03:41:22 PM
#9250   We are about to get creamed here. Mokyo Toe 10/19/17 09:49:28 AM
#9249   I think you are really asking two questions... Mokyo Toe 10/19/17 12:11:57 AM
#9248   Thoughts on the news regarding the PVCT PPS shawnb 10/18/17 01:13:18 PM
#9247   NEWS -- PROVECTUS ANNOUNCES PRELIMINARY RESULTS FROM PHASE Paulness 10/18/17 11:29:03 AM
#9246   Just saw this, thanks for posting it bombaytonic. Mokyo Toe 10/18/17 08:43:56 AM
#9245   PR - https://www.sec.gov/Archives/edgar/data/315545/000149315217011744/ex99-1.htm bombaytonic 10/18/17 08:00:29 AM
#9244   Sweet! I made a sticky of it. Mokyo Toe 10/18/17 12:36:17 AM
#9243   NEW DATA RELEASE: Preliminary Results of a Phase Mokyo Toe 10/18/17 12:34:44 AM
#9242   Here is the poster they presented http://provectusbio.com/media/docs/publications/SMR-2017-Poster-P1 jondoeuk 10/18/17 12:26:30 AM
#9241   Called it several days ago that clinical update bluuoforange 10/17/17 12:06:57 PM
#9240   Robust volume and buying this first hour. Mokyo Toe 10/17/17 10:29:40 AM
#9239   Nice volume yesterday. Dragonwing 10/17/17 09:14:35 AM
#9238   Very interesting update. :) RiverWolf 10/16/17 08:29:01 PM
#9237   The longest journey begins with a single step, Mokyo Toe 10/16/17 03:53:51 PM
#9236   I am with this company to the end Egy_Pharaoh 10/16/17 11:57:16 AM
#9235   If we chew through these last .035's, this Mokyo Toe 10/16/17 11:43:15 AM
#9234   Gap has now filled. If this thing Mokyo Toe 10/16/17 10:01:51 AM
#9233   Looks like a gap up this morning. Should bombaytonic 10/16/17 09:14:06 AM
#9232   I doubt $1 will be on the horizon Mokyo Toe 10/16/17 03:57:59 AM
#9231   Here is the abstract http://www.mciberlin.de/WCM2017/P15-1.pdf Let's hope the jondoeuk 10/15/17 11:46:53 PM
#9230   What could be the PVCT price target now shawnb 10/15/17 09:42:41 PM
#9229   This is what we have been waiting for. Mokyo Toe 10/15/17 12:33:47 PM
#9228   Also, is it the reason that PRH has bombaytonic 10/14/17 10:53:59 PM
#9227   Interesting. First piece of data to be released bombaytonic 10/14/17 10:51:48 PM
#9226   P15-1- Preliminary results of a Phase 1b/2 study jondoeuk 10/14/17 09:32:37 AM
#9225   Personally, I have only been in this thing Mokyo Toe 10/13/17 12:56:33 AM
PostSubject